Celocentesis for Prenatal Diagnosis of Rare Monogenic Diseases: Development, Validation, and Clinical Outcome on 876 Cases
Prenatal Diagnosis · 2026-08 · 46 (9) · 1411-1422
DOI: 10.1002/pd.70184 ↗Kurz gefasst
Fachartikel in der Zeitschrift Prenatal Diagnosis, online erschienen am 23.05.2026. Verfasst von Antonino Giambona und 12 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Molecular Diagnostic Rare Hematological Diseases, Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy. Hauptthemen laut MEDLINE: Prenatal Diagnosis, Rare Diseases, Genetic Diseases, Inborn, Paracentesis. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objective
To report on the development, validation, and clinical outcomes of 876 consecutive cases of prenatal diagnosis of rare monogenic diseases using celocentesis.
Methods
This retrospective single‐center study, conducted between April 2006 and December 2025, evaluated celomic fluid collected at 7–9 weeks of gestation from women at risk of carrying fetuses with monogenic diseases. Fetal DNA was obtained by isolating embryo‐fetal erythroid precursors. All samples were assessed for the presence of parental molecular defects and maternal cell contamination (MCC).
Results
The median gestational age at the time of celocentesis was 8.4 weeks. Successful aspiration of celomic fluid was achieved in 875/876 cases (99.9%). Although MCC was observed in 98.74% of the samples, an initial subset of 19/190 (10%) was found unsuitable for molecular analysis. Subsequently, an optimized molecular workflow was successfully applied to the remaining cohort, achieving a success rate of 98% (671/685 procedures). Results were validated against confirmatory samples from abortive tissue (following VIP), amniotic fluid, or postnatal blood. All cases were correctly classified, demonstrating 100% sensitivity and specificity.
Conclusion
This study supports the clinical application of celocentesis as a reliable early prenatal diagnostic procedure for monogenic diseases. It represents a viable alternative to Chorionic Villus Sampling (CVS) and amniocentesis, enabling invasive prenatal diagnosis at a significantly earlier stage of pregnancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Unit of Molecular Diagnostic Rare Hematological Diseases, Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy.
- Department of Obstetrics & Gynecology, University Hospital of Ioannina, Ioannina, Greece.
- Foundation Franco and Piera Cutino, Palermo, Italy.
- Unit of Fetal Medicine and Prenatal Diagnosis, Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy.
- Harris Birthright Research Centre for Fetal Medicine, King's College Hospital, London, UK.
Zitieren
APA
Giambona, A., Makrydimas, G., Maggio, A., Cassarà, F., Marchese, G., Leto, F., Marotta, S., Cigna, V., Orlandi, E., Mugavero, M. E., Nicolaides, K. H., Vinciguerra, M., & Picciotto, F. (2026). Celocentesis for Prenatal Diagnosis of Rare Monogenic Diseases: Development, Validation, and Clinical Outcome on 876 Cases. Prenatal Diagnosis, 46(9), 1411-1422. https://doi.org/10.1002/pd.70184
Vancouver
Giambona A, Makrydimas G, Maggio A, Cassarà F, Marchese G, Leto F, et al. Celocentesis for Prenatal Diagnosis of Rare Monogenic Diseases: Development, Validation, and Clinical Outcome on 876 Cases. Prenatal Diagnosis. 2026;46(9):1411-1422. doi:10.1002/pd.70184
BibTeX
@article{Giambona2026,
author = {Giambona, Antonino and Makrydimas, George and Maggio, Aurelio and Cassarà, Filippo and Marchese, Giuseppe and Leto, Filippo and Marotta, Susanna and Cigna, Valentina and Orlandi, Emanuela and Mugavero, Maria Elena and Nicolaides, Kypros H and Vinciguerra, Margherita and Picciotto, Francesco},
title = {Celocentesis for Prenatal Diagnosis of Rare Monogenic Diseases: Development, Validation, and Clinical Outcome on 876 Cases},
journal = {Prenatal Diagnosis},
year = {2026},
volume = {46},
number = {9},
pages = {1411--1422},
doi = {10.1002/pd.70184}
}
EUVIMED